Edition:
India

Core Laboratories NV (CLB.N)

CLB.N on New York Stock Exchange

116.00USD
19 Jan 2018
Change (% chg)

$0.70 (+0.61%)
Prev Close
$115.30
Open
$114.55
Day's High
$116.65
Day's Low
$114.20
Volume
121,185
Avg. Vol
155,433
52-wk High
$124.85
52-wk Low
$86.55

Latest Key Developments (Source: Significant Developments)

Core Laboratories qtrly ‍revenue $166.2 mln vs $143.5 mln
Tuesday, 24 Oct 2017 

Oct 23 (Reuters) - Core Laboratories NV : :Core Laboratories NV qtrly ‍revenue $166.2 million versus $143.5 million.Core Laboratories NV - qtrly earnings per share $0.48‍​.Core Laboratories NV - ‍eps for q4 2017 is expected to be approximately $0.58​.Core Laboratories NV sees Q4 2017 revenue of approximately $171.5 million.Q4 earnings per share view $0.58, revenue view $171.3 million -- Thomson Reuters I/B/E/S.Q3 earnings per share view $0.44, revenue view $161.4 million -- Thomson Reuters I/B/E/S.  Full Article

Core Laboratories CEO David Demshur's 2016 total compensation was $6.2 mln
Saturday, 25 Mar 2017 

Core Laboratories Nv - :CEO David Demshur's fy 2016 total compensation was $6.2 million versus $6.6 million in fy 2015 - sec filing.  Full Article

Core Laboratories N.V. Q2 revenue of $148.1 mln decreased 3.6 pct sequentially
Thursday, 21 Jul 2016 

Core Laboratories N.V. : Second quarter EPS of $0.38 GAAP; EPS of $0.35, excluding items . At current activity levels, core predicts 2016 U.S. onshore oil production will fall approximately 1,100,000 bopd . Second quarter revenue of $148.1 million decreased 3.6 pct sequentially .Q2 earnings per share view $0.35, revenue view $146.4 million -- Thomson Reuters I/B/E/S.  Full Article

Core Lab prices upsized public offering of 1.5 mln share
Thursday, 12 May 2016 

Core Laboratories Nv : Says upsized pricing of an underwritten public offering of 1,475,000 shares of its common stock . Gross proceeds of offering (before underwriter's discounts and commissions and estimated offering expenses) will be about $175 million .Core Lab announces upsizing and pricing of public offering of common stock.  Full Article

Core Lab prices upsized public offering of 1.5 mln share
Thursday, 12 May 2016 

Core Laboratories Nv : Says upsized pricing of an underwritten public offering of 1,475,000 shares of its common stock . Gross proceeds of offering (before underwriter's discounts and commissions and estimated offering expenses) will be about $175 million .Core Lab announces upsizing and pricing of public offering of common stock.  Full Article

Core laboratories NV files for stock shelf of up to 1.3 mln shares
Thursday, 12 May 2016 

Core Laboratories NV :Core Laboratories NV files for stock shelf of up to 1.3 million shares of common stock - SEC Filing.  Full Article

Core Laboratories commences underwritten public offering of 1.3 mln shares
Thursday, 12 May 2016 

Core Laboratories NV : Commenced a registered underwritten public offering of 1,300,000 shares of its common stock .Proceeds from offering will be used to repay a portion of outstanding borrowings under our revolving credit facility.  Full Article

Core Laboratories NV announces Q2 quarterly dividend
Friday, 15 Apr 2016 

Core Laboratories NV:Cash dividend of $0.55 per share of common stock payable in the second quarter of 2016.Says dividend will be payable on May 24 to shareholders of record date as on May 4.  Full Article

BRIEF-Core Laboratories qtrly ‍revenue $166.2 mln vs $143.5 mln

* Core Laboratories NV qtrly ‍revenue $166.2 million versus $143.5 million